{"id":6778,"date":"2025-09-11T23:02:47","date_gmt":"2025-09-11T23:02:47","guid":{"rendered":"https:\/\/mailitics.com\/index.php\/2025\/09\/11\/fda-non-opioid-painkillers-psychedelics-soon-shiong\/"},"modified":"2025-09-11T23:02:47","modified_gmt":"2025-09-11T23:02:47","slug":"fda-non-opioid-painkillers-psychedelics-soon-shiong","status":"publish","type":"post","link":"https:\/\/mailitics.com\/index.php\/2025\/09\/11\/fda-non-opioid-painkillers-psychedelics-soon-shiong\/","title":{"rendered":"STAT+: FDA pushing non-opioid path for chronic pain"},"content":{"rendered":"<p>    STAT+: FDA pushing non-opioid path for chronic pain<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n    <!-- no image --><br \/>\n \t<BR><br \/>\n<BR><\/BR><\/p>\n<div>\n<p><em>Want to stay on top of the science and politics driving biotech today?\u00a0<a href=\"https:\/\/www.statnews.com\/signup\/readout\/\">Sign up<\/a>\u00a0to get our biotech newsletter in your inbox.<\/em><\/p>\n<p>Morning. Today, we note that psychedelics are suddenly a hot topic for larger pharmaceutical companies, dissect Patrick Soon-Shiong\u2019s claims on his lung cancer drug, and more.<\/p>\n<h2 class=\"wp-block-heading\" id=\"h-pharma-is-quickly-warming-to-psychedelics\">Pharma is quickly warming to psychedelics<\/h2>\n<p>AbbVie\u2019s $1.2 billion move to buy Gilgamesh\u2019s psychedelic candidate is the first time a traditional drugmaker has snapped up an investigational psychedelic \u2014 a milestone that analysts say could trigger a wave of follow-on deals, STAT\u2019s Olivia Goldhill writes.<\/p>\n<p><a href=\"https:\/\/www.statnews.com\/2025\/09\/11\/fda-non-opioid-painkillers-psychedelics-soon-shiong\/?utm_campaign=rss\">Continue to STAT+ to read the full story\u2026<\/a><\/p>\n<\/div>\n<p> \t<BR><br \/>\n <BR><\/BR><br \/>\n    Meghana Keshavan<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n<a href=\"https:\/\/www.statnews.com\/2025\/09\/11\/fda-non-opioid-painkillers-psychedelics-soon-shiong\/?utm_campaign=rss\">Go to statnews<\/a><br \/>\n \t<BR><br \/>\n <BR><\/BR><\/p>\n","protected":false},"excerpt":{"rendered":"<p>STAT+: FDA pushing non-opioid path for chronic pain Want to stay on top of the science and politics driving biotech today?\u00a0Sign up\u00a0to get our biotech newsletter in your inbox. Morning. Today, we note that psychedelics are suddenly a hot topic for larger pharmaceutical companies, dissect Patrick Soon-Shiong\u2019s claims on his lung cancer drug, and more. [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2194,2154,58,2159,2208,2182,2176,858,2207],"tags":[2150],"class_list":["post-6778","post","type-post","status-publish","format-standard","hentry","category-biotech","category-biotechnology","category-business","category-cancer","category-drug-development","category-drug-pricing","category-pharma","category-research","category-the-readout","tag-statnews"],"_links":{"self":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/6778"}],"collection":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/comments?post=6778"}],"version-history":[{"count":0,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/6778\/revisions"}],"wp:attachment":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/media?parent=6778"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/categories?post=6778"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/tags?post=6778"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}